UK NICE is an official public source that HealthSignal monitors for Market Access & Reimbursement, Digital Health & AI, General Regulatory. The most recent updates we have tracked from it are listed below, each normalised into our index and linked back to the original publication on the source's own website.
People in England with a type of chronic heart failure could benefit from a new treatment option. Our final draft guidance recommends finerenone for adults with chronic heart failure with preserved or mildly reduced e...
UK NICEA procedure that keeps donor livers supplied with oxygen inside the body before removal has been recommended for NHS use and could help more people on the transplant waiting list.
UK NICEPeople with polyendocrine metabolic ovarian syndrome (PMOS) should have their condition diagnosed sooner and be offered an annual review to monitor symptoms, treatment and long-term health risks, according to our draf...
UK NICEA new treatment option is now available on the NHS for cervical cancer that has come back or spread to other parts of the body, following our final draft guidance published today.
UK NICELearn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.
UK NICEWomen with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published today by NICE.
UK NICEWe’ve recommended that newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home if they are doing well and responding to treatment.
UK NICEIn this episode of NICE Talks, we're covering some of the most significant guidance updates of the year so far for women's health and cancer care. Podcasts 01 May 2026
UK NICEWe’ve recommended a new treatment called rozanolixizumab for some adults living with generalised myasthenia gravis (gMG) whose symptoms are not controlled by existing treatments.
UK NICENICE has been commissioned by the Department of Health and Social Care and NHS England to adapt the evidence standards framework for digital health technologies to support evidence-based decision making for digital ca...
UK NICEWe have launched a public consultation on the proposed adoption of the new EQ-5D-5L value set which will help us to make more accurate assessments of how treatments improve health-related quality of life.
UK NICEThe updated fertility guideline includes a brand-new section specifically for those with endometriosis who are struggling to conceive - published to coincide with the final day of Endometriosis Action Month.
UK NICESophie Cooper, senior scientific adviser in NICE’s science policy team, explains the importance of the recently published EQ-5D-5L value set and how it has the potential to help us decide if new treatments offer good ...
UK NICEPatients in England are set to receive some new medicines 3 to 6 months earlier under a streamlined approval process being launched by the MHRA and NICE.
UK NICEIn this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. Podcasts 26 February 2026
UK NICEAhead of Rare Disease Day on 28 February, we've published our first ever quality standard on rare diseases, and the first to have been developed in partnership with an external organisation.
UK NICEWe look back on the guidance we've produced in 2025. Podcasts 17 December 2025
UK NICEBreakthrough therapy reduces flare-ups by almost a third and could ease pressure on NHS hospitals.
UK NICEAn online therapy programme can be used to help people aged 16 and over with eating disorders whilst they wait for specialist NHS treatment, an independent NICE has said.
UK NICEMore women with ovarian cancer could be diagnosed earlier under proposed new NICE guidance that replaces a one-size-fits-all blood test threshold with personalised, age-based criteria.
UK NICEMore than 7,000 people in England will now be able to access to a life-extending treatment for advanced bowel cancer.
UK NICEPatients aged 16 or over with suspected sepsis will receive more tailored treatment under updated NICE guidance published today.
UK NICEFive smart technologies that act as a "second pair of eyes" during bowel examinations have been conditionally recommended by NICE for NHS use, potentially helping doctors spot harmful growths that could turn into cancer.
UK NICEPeople living with metastatic prostate cancer in England will gain access to a new treatment combination from today (Friday, 24 October), following a recommendation by NICE.
UK NICEThe new treatment offers hope to thousands living with advanced urothelial cancer, with clinical trials showing overall survival rates were almost twice as long compared to standard treatment.
UK NICEIn final draft guidance published today we've confirmed that we’re unable to recommend cerliponase alfa (also called Brineura and made by BioMarin) for routine NHS use in treating neuronal ceroid lipofuscinosis type 2...
UK NICENew guidance aims to reduce variation in treatment and prevent unnecessary surgery, improving care for patients and supporting healthcare professionals.
UK NICE